These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24269854)

  • 1. Prognostic significance of ECG abnormalities for mortality risk in acute heart failure: insight from the Sub-Saharan Africa Survey of Heart Failure (THESUS-HF).
    Dzudie A; Milo O; Edwards C; Cotter G; Davison BA; Damasceno A; Mayosi BM; Mondo C; Ogah O; Ojji D; Sani MU; Sliwa K
    J Card Fail; 2014 Jan; 20(1):45-52. PubMed ID: 24269854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Readmission and death after an acute heart failure event: predictors and outcomes in sub-Saharan Africa: results from the THESUS-HF registry.
    Sliwa K; Davison BA; Mayosi BM; Damasceno A; Sani M; Ogah OS; Mondo C; Ojji D; Dzudie A; Kouam Kouam C; Suliman A; Schrueder N; Yonga G; Ba SA; Maru F; Alemayehu B; Edwards C; Cotter G
    Eur Heart J; 2013 Oct; 34(40):3151-9. PubMed ID: 24048728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries.
    Damasceno A; Mayosi BM; Sani M; Ogah OS; Mondo C; Ojji D; Dzudie A; Kouam CK; Suliman A; Schrueder N; Yonga G; Ba SA; Maru F; Alemayehu B; Edwards C; Davison BA; Cotter G; Sliwa K
    Arch Intern Med; 2012 Oct; 172(18):1386-94. PubMed ID: 22945249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical activity measured with implanted devices predicts patient outcome in chronic heart failure.
    Conraads VM; Spruit MA; Braunschweig F; Cowie MR; Tavazzi L; Borggrefe M; Hill MR; Jacobs S; Gerritse B; van Veldhuisen DJ
    Circ Heart Fail; 2014 Mar; 7(2):279-87. PubMed ID: 24519908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptoms and Signs of Heart Failure at Admission and Discharge and Outcomes in the Sub-Saharan Acute Heart Failure (THESUS-HF) Registry.
    Sani MU; Cotter G; Davison BA; Mayosi BM; Damasceno A; Edwards C; Ogah OS; Mondo C; Dzudie A; Ojji DB; Kouam Kouam C; Suliman A; Yonga G; Abdou Ba S; Maru F; Alemayehu B; Sliwa K
    J Card Fail; 2017 Oct; 23(10):739-742. PubMed ID: 27664511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the importance of the electrocardiogram in patients with acute heart failure.
    Gouda P; Brown P; Rowe BH; McAlister FA; Ezekowitz JA
    Eur J Heart Fail; 2016 Aug; 18(8):1032-40. PubMed ID: 27145910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of indeterminable anaerobic threshold in heart failure.
    Agostoni P; Corrà U; Cattadori G; Veglia F; Battaia E; La Gioia R; Scardovi AB; Emdin M; Metra M; Sinagra G; Limongelli G; Raimondo R; Re F; Guazzi M; Belardinelli R; Parati G; Magrì D; Fiorentini C; Cicoira M; Salvioni E; Giovannardi M; Mezzani A; Scrutinio D; Di Lenarda A; Mantegazza V; Ricci R; Apostolo A; Iorio A; Paolillo S; Palermo P; Contini M; Vassanelli C; Passino C; Piepoli MF;
    Circ Heart Fail; 2013 Sep; 6(5):977-87. PubMed ID: 23881847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial.
    Mentz RJ; Chung MJ; Gheorghiade M; Pang PS; Kwasny MJ; Ambrosy AP; Vaduganathan M; O'Connor CM; Swedberg K; Zannad F; Konstam MA; Maggioni AP
    Am Heart J; 2012 Dec; 164(6):884-92.e2. PubMed ID: 23194489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QRS prolongation in the prediction of clinical cardiac events in patients with acute heart failure: analysis of data from the Korean Acute Heart Failure Registry.
    Park HS; Kim H; Park JH; Han S; Yoo BS; Shin MS; Seong IW; Ahn Y; Kang SM; Kim JJ; Jeon ES; Cho MC; Choi DJ; Chae SC; Kim YJ; Seo HS; Oh BH; Lee MM; Ryu KH
    Cardiology; 2013; 125(2):96-103. PubMed ID: 23711763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial.
    Ambrosy AP; Vaduganathan M; Mentz RJ; Greene SJ; Subačius H; Konstam MA; Maggioni AP; Swedberg K; Gheorghiade M
    Am Heart J; 2013 Feb; 165(2):216-25. PubMed ID: 23351825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%.
    Cygankiewicz I; Zareba W; Vazquez R; Bayes-Genis A; Pascual D; Macaya C; Almendral J; Fiol M; Bardaji A; Gonzalez-Juanatey JR; Nieto V; Valdes M; Cinca J; de Luna AB;
    Am J Cardiol; 2009 Apr; 103(7):1003-10. PubMed ID: 19327431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).
    Ruwald MH; Ruwald AC; Jons C; Alexis J; McNitt S; Zareba W; Moss AJ
    J Am Coll Cardiol; 2013 Apr; 61(14):1518-26. PubMed ID: 23500269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Lip GY
    Eur J Heart Fail; 2013 Apr; 15(4):415-24. PubMed ID: 23302606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of low body temperature and poor outcomes in patients admitted with worsening heart failure: a substudy of the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) trial.
    Payvar S; Spertus JA; Miller AB; Casscells SW; Pang PS; Zannad F; Swedberg K; Maggioni AP; Reid KJ; Gheorghiade M;
    Eur J Heart Fail; 2013 Dec; 15(12):1382-9. PubMed ID: 23858000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low prealbumin is strongly associated with adverse outcome in heart failure.
    Lourenço P; Silva S; Friões F; Alvelos M; Amorim M; Couto M; Torres-Ramalho P; Guimarães JT; Araújo JP; Bettencourt P
    Heart; 2014 Nov; 100(22):1780-5. PubMed ID: 24986895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) trial.
    Greene SJ; Vaduganathan M; Wilcox JE; Harinstein ME; Maggioni AP; Subacius H; Zannad F; Konstam MA; Chioncel O; Yancy CW; Swedberg K; Butler J; Bonow RO; Gheorghiade M;
    JACC Heart Fail; 2013 Dec; 1(6):488-96. PubMed ID: 24622000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echocardiographic predictors of outcome in acute heart failure patients in sub-Saharan Africa: insights from THESUS-HF.
    Sani MU; Davison BA; Cotter G; Damasceno A; Mayosi BM; Ogah OS; Mondo C; Dzudie A; Ojji DB; Kouam CK; Suliman A; Yonga G; Ba SA; Maru F; Alemayehu B; Edwards C; Sliwa K
    Cardiovasc J Afr; 2017; 28(1):60-67. PubMed ID: 28262911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.
    Vaduganathan M; Ambrosy AP; Greene SJ; Mentz RJ; Subacius HP; Maggioni AP; Swedberg K; Nodari S; Zannad F; Konstam MA; Butler J; Gheorghiade M;
    Circ Heart Fail; 2012 Nov; 5(6):750-8. PubMed ID: 23051949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive prognostic value of subjective assessment with respect to clinical cardiological data in patients with chronic heart failure.
    Majani G; Pierobon A; Pinna GD; Giardini A; Maestri R; La Rovere MT
    Eur J Cardiovasc Prev Rehabil; 2011 Dec; 18(6):836-42. PubMed ID: 21450593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure.
    Rychli K; Richter B; Hohensinner PJ; Kariem Mahdy A; Neuhold S; Zorn G; Berger R; Mörtl D; Huber K; Pacher R; Wojta J; Niessner A; Hülsmann M
    Heart; 2011 Jul; 97(14):1158-63. PubMed ID: 21572126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.